Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1989-11-09
1992-08-04
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514824, 514863, 514866, 536 11, 536112, 536118, 536122, A61K 906, A61K 31715
Patent
active
051359200
ABSTRACT:
Dextran sulfate, .beta.-1,3-glucan sulfate, and the salts thereof are angiostatic and useful for treatment and prevention of various diseases caused by abnormally accelerated angiogenesis. Combination of such a compound with a steroidal or non-steroidal substance increases the angiostatic activity of each compound to induce the combined effect.
REFERENCES:
patent: 3754925 (1973-08-01), Kimura et al.
patent: 4207312 (1980-06-01), Fujii et al.
patent: 4767614 (1988-08-01), Scarpa et al.
patent: 4793336 (1988-12-01), Wang
patent: 4820693 (1989-04-01), Gillespie
patent: 4833131 (1989-05-01), Williams et al.
patent: 4840941 (1989-06-01), Ueno et al.
patent: 4876250 (1989-10-01), Clark
patent: 4895838 (1990-01-01), McCluer et al.
patent: 4912093 (1990-03-01), Michaeli
patent: 4921838 (1990-05-01), Catsimpoolas et al.
patent: 4965347 (1990-10-01), Misaki et al.
patent: 4966890 (1990-10-01), Gillespie
patent: 5055301 (1991-10-01), Voigt et al.
Ingber et al., "A Possible Mechanism for Inhibition of Angiogenesis by Angiostatic Steroids:Induction of Capillary Basement Membrane Dissolution"; Endocrinology, vol. 119, No. 4, Oct. 1986, pp. 1768-1775.
Taylor et al., "Protamine is an inhibitor of angiogenesis"; Nature, vol. 297, May 27, 1982, pp. 307-312.
Advances in Cancer Research, 43, 175 (1985).
Science, 221, 719 (1983).
Annals of Surgery, 206, 374 (1987).
Laboratory investigation, 59, 44 (1988).
J. Pharmacol. Exp. Ther., 244, 729 (1988).
The Merck Index, 9th edition, 1976, Paragraph 2907, p. 387.
The Merck Index, 11th edition, 1989, Paragraph 2925, pp. 464-465 and Paragraph 4571, p. 735.
Carbohydrate Res., 17, 109 (1971).
J. Biol. Chem., 239, 2986 (1964).
J. Antibiotics, 34, 1355 (1981).
Biochem. Pharmacology, 31, 915 (1982).
J. Antiobiotics, 40, 1231 (1987).
J. Antiboitcs, 40, 1239 (1987).
J. Am. Chem. Soc., 83, 3096 (1961).
Science, 230, 1375 (1985).
Endocr. 1768-1775 (1986), vol. 119, Ingber, et al.
Kanamaru Tsuneo
Nozaki Yukimasa
Sudo Katsuichi
Conlin David G.
Griffin Ronald W.
Resnick David S.
Takeda Chemical Industries Ltd.
Williams Gregory D.
LandOfFree
Angiostatic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Angiostatic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiostatic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-778423